Now that the Abbott Freestyle Libre has received FDA clearance, Abbott and Dexcom will be forced into tight competition in the US market. On Dexcom’s third quarter call, CEO Kevin Sayer spent some ...
Dexcom enjoys a well-established track record for introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, Dexcom has captured an impressive ...
On the heels of a first quarter that saw its sales slip and operating loss widen, Tandem Diabetes Care is banking on making big moves in the second half of the year to turn things around. Though the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback